Skip to main content

Table 4 Difference between hematic crasis at baseline, post vax 1 and post vax 2 in the cohort under IO treatment

From: Exploring hematic crasis variations in cancer patients following SARS-CoV-2 vaccination: a real-practice study

Variable

N = 35

Pre-vax

Post-vax 1

Post-vax 2

Pre-vax vs. Post-vax 1

p-value

Pre-vax vs. Post-vax 2

p-value

Post-vax 1 vs. Post-vax 2

p-value

WBC counts

6.15 (2.39)

6.38 (2.37)

6.21 (2.02)

0.4804

0.8602

0.4156

Neutrophils

3.71 (2.11)

3.80 (2.02)

3.55 (1.46)

0.8526

0.7188

0.5564

Lymphocytes

1.75 (0.88)

1.75 (0.86)

1.85 (0.96)

0.9792

0.6535

0.6691

Platelets

235 (68)

250 (127)

222 (52)

0.5414

0.3934

0.2433

Hemoglobin

13.22 (1.29)

12.97 (1.41)

13.02 (1.49)

0.445

0.556

0.8825